{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:13:12Z","timestamp":1783692792695,"version":"3.55.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125927","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T14:03:41Z","timestamp":1432735421000},"page":"e0125927","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Structure-Activity Relationships for the Antifungal Activity of Selective Estrogen Receptor Antagonists Related to Tamoxifen"],"prefix":"10.1371","volume":"10","author":[{"given":"Arielle","family":"Butts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"DiDone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Mutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J.","family":"Krysan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"ref1","first-page":"507","article-title":"Cryptococcosis. Infect Dis Clin N Amer","volume":"20","author":"M Chayakulkeeree","year":"2006","journal-title":"Cryptococcosis. Infect Dis Clin N Amer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12281-012-0111-0","article-title":"Cryptococcus gattii, no longer an accidental pathogen","volume":"6","author":"DJ Springer","year":"2012","journal-title":"Curr Fungal Infect. Rep."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"R Perfect J","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination therapy for cryptococcal meningitis","volume":"368","author":"JN Day","year":"2013","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QCO.0b013e32832fa214","article-title":"Treatment of cryptococcal meningitis in resource-limited settings","volume":"22","author":"DJ Sloan","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of combined cohort of 262 patients","volume":"49","author":"T Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Krysan DJ. 2014. Towards improving anti-cryptococcal drugs: novel molecules and re-purposed drugs. Fungal Genet Biol. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.fgb.2014.12.001\" xlink:type=\"simple\">10.1016\/j.fgb.2014.12.001<\/ext-link><\/comment>","DOI":"10.1016\/j.fgb.2014.12.001"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1002870","DOI":"10.1371\/journal.ppat.1002870","article-title":"Antifungal drug discovery: something old and something new","volume":"8","author":"A Butts","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2174\/156802612804547344","article-title":"Drug repurposing in chemical genomics: can we learn from the past to improve the future?","volume":"12","author":"W. Bisson","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/EC.00314-12","article-title":"2013. A re-purposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis","volume":"12","author":"A Butts","year":"2013","journal-title":"Eukaryot Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e00765","DOI":"10.1128\/mBio.00765-13","article-title":"Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF-hand proteins and synergize with fluconazole in vivo","volume":"5","author":"A Butts","year":"2014","journal-title":"mBio"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-200342040-00004","article-title":"Pharmacokinetics of selective estrogen receptor modulators","volume":"42","author":"KC Morello","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.1991.147","article-title":"Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients","volume":"63","author":"EA Lein","year":"1991","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system","volume":"9","author":"K Voelz","year":"2010","journal-title":"Eukaryot Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jac\/34.6.1051","article-title":"Synergic activity of amphotericin-B and gamma interferon against intracellular <italic>Cryptococcus neoformans<\/italic> in macrophages","volume":"34","author":"JL Herrmann","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1042\/bst0171038","article-title":"Observation and significance of growth inhibition of <italic>Saccharomyces cerevisiae<\/italic> (A224A) by the anti-oestrogen drug tamoxifen","volume":"17","author":"H Wiseman","year":"1989","journal-title":"Biochem Soc Trans"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/AAC.01564-08","article-title":"The antifungal activity of tamoxifen: in vitro, in vivo, and mechanistic characterization","volume":"53","author":"K Dolan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/msb.2011.31","article-title":"Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole","volume":"7","author":"M Spitzer","year":"2011","journal-title":"Mol Syst Biol"},{"key":"ref20","first-page":"e01126","article-title":"Triphenylethylenes, a novel class of antifungals","volume":"5","author":"AR Odom","year":"2014","journal-title":"mBio"},{"key":"ref21","first-page":"2753","article-title":"Ca<sup>2+<\/sup>-dependent binding of tamoxifen to calmodulin isolated from bovine brain","volume":"50","author":"F Lopes","year":"1990","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0006-291X(03)01528-6","article-title":"Coping with stress: calmodulin and calcineurin in model and pathogenic fungi","volume":"311","author":"PR Kraus","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e51403","DOI":"10.1371\/journal.pone.0051403","article-title":"The Crz1\/Sp1 transcription factor of <italic>Cryptococcus neoformans<\/italic> is activated by calcineurin and regulates cell wall integrity","volume":"7","author":"S Lev","year":"2012","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/jm9505472","article-title":"Homologs of Idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length","volume":"39","author":"IR Hardcastle","year":"1996","journal-title":"J Med Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1021\/bi980795a","article-title":"Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies","volume":"37","author":"BG Vertessy","year":"1998","journal-title":"Biochemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1021\/bi00255a006","article-title":"Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex","volume":"33","author":"WJ Cook","year":"1994","journal-title":"Biochemistry"},{"key":"ref27","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards. Wayne, PA."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:20:40Z","timestamp":1588965640000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125927"}},"subtitle":[],"editor":[{"given":"Yong-Sun","family":"Bahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125927","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}